短链脂肪酸是糖尿病视网膜病变免疫调节的潜在生物标志物
研究纳入165例糖尿病患者,用气相色谱-质谱法检测血浆短链脂肪酸(SCFAs),并用Olink平台分析蛋白组;结果显示糖尿病视网膜病变(DR)患者循环SCFAs谱与非DR对照显著不同,乙酸、丁酸、异丁酸和异戊酸水平较低与DR风险强相关,且蛋白组显示免疫失调、细胞因子与SCFA水平密切相关。在链脲佐菌素诱导糖尿病小鼠中,补充乙酸16周改善肠道屏障功能、减轻视网膜变薄并防止血管丢失,同时降低CD45+CD11b+细胞和F4/80+CD206+CD11c-细胞频率,并引起视网膜DNA甲基化改变,包括血管内皮生长因子和核因子-κB等关键通路下调。
要点
- DR患者循环乙酸、丁酸、异丁酸和异戊酸水平较低与DR风险强相关。
- DR患者存在免疫失调,细胞因子表达与SCFA水平密切相关。
- 糖尿病小鼠补充乙酸16周改善肠道屏障、减轻视网膜变薄并防止血管丢失。
核心结论
- 研究揭示了循环SCFAs、免疫调节与DR发展之间具有机制和转化相关性的相互关系。
研究设计与样本
- 收集165例糖尿病患者的血液样本,用气相色谱-质谱法定量血浆SCFAs,并用Olink平台探索反映宿主对循环SCFAs反应的蛋白组谱。
- 采用链脲佐菌素诱导的糖尿病小鼠模型,评估补充乙酸16周后的视网膜形态学、病理学和表观遗传学变化。
主要发现
- DR患者的循环SCFA谱与非DR对照显著不同;乙酸、丁酸、异丁酸和异戊酸水平较低与DR风险强相关。
- 蛋白组分析显示DR患者存在免疫失调,细胞因子表达与SCFA水平密切相关。
- 糖尿病小鼠补充乙酸后肠道屏障功能改善、视网膜变薄减轻、血管丢失被防止。
- 乙酸降低CD45+ CD11b+细胞和F4/80+ CD206+ CD11c-细胞频率,表明对糖尿病视网膜过度活跃的免疫系统有显著抑制。
- 观察到视网膜DNA甲基化显著变化,包括血管内皮生长因子和核因子-κB等关键通路下调。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Gut microbiota is involved in the pathophysiology of diabetes and its complications, yet the mechanistic link of short-chain fatty acids (SCFAs) produced by gut microbes in the pathogenesis of diabetic retinopathy (DR) remains unclear. The objective of the current study was to investigate the involvement of SCFAs in the development of DR. METHODS: We collected blood samples from 165 participants with diabetes mellitus and quantified plasma SCFAs using gas chromatography-mass spectrometry. Additionally, we explored proteomic profiles reflecting host responses to circulating SCFAs using the Olink platform. Using a streptozotocin-induced diabetic mouse model, we evaluated retinal morphological, pathological, and epigenetic changes following a 16-week acetate supplementation. RESULTS: Our data showed that the circulating SCFA profiles of patients with DR significantly differed from those of non-DR controls. Lower levels of acetic, butyric, iso-butyric, and iso-valeric acids were strongly associated with DR risk. Proteomic analysis revealed immune dysregulation in patients with DR, with cytokine expression closely correlated with SCFA levels. In diabetic mice, acetate supplementation improved intestinal barrier function, alleviated retinal thinning, and prevented vessel loss. Moreover, acetate decreased the frequency of CD45+ CD11b+ cells and F4/80+ CD206+ CD11c- cells, indicating a significant inhibition of the overactive immune system in the diabetic retina. Finally, we observed significant changes in retinal DNA methylation, including downregulation of key pathways like vascular endothelial growth factor and nuclear factor-kappa B. CONCLUSIONS: These findings reveal mechanistic and translationally relevant inter-relationships among the circulating SCFAs, immune regulation, and the development of DR.
引用
- Qin X, Sun J, Xu Y, et al. Short-Chain Fatty Acids Are Potential Biomarkers of Immune Regulation in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2025. PMID: 40478560. doi:10.1167/iovs.66.6.23
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。